Pfizer in Conflict with Activist Investor: Tensions with Starboard Value Escalate

The pharmaceutical giant Pfizer is facing increasing tensions with the activist investor Starboard Value. The background to the dispute is Starboard's demand for an investigation into the decisions of Pfizer's board of directors. Health industry expert Anjalee Khemlani from Yahoo Finance sheds light on the chronology of events and Starboard Value's growing involvement with Pfizer. She analyzes the factors that have led to the current conflict situation. Interested parties can follow further insights and analyses on the current market situation on the Market Domination Overtime show.